| NICE[@26236; @26237] |
2016 |
Ultrasound screening every 6 months for adults with cirrhosis |
|
|
Ultrasound screening every 6 months with alpha-fetoprotein measurement for adults with chronic hepatitis B |
| AASLD[@26238] |
2018 |
Ultrasound with or without AFP every 6 months |
| ACR[@26239] |
2017 |
Ultrasound recommended except in subgroups with technical limitations where CT or MRI is recommended (eg, obesity, fatty liver, nodular cirrhotic liver) |
| APASL[@26240] |
2017 |
Ultrasound and AFP every 6 months |
|
|
AFP alone not recommended |
| EASL[@26241] |
2018 |
Ultrasound every 6 months |
|
|
No recommendation for AFP |
| JSH[@26242] |
2014 |
Extremely high-risk patients: ultrasound every 3-4 months, AFP every 3-4 months, Computed tomography/magnetic resonance imaging (optional) every 6-12 months |
|
|
High risk: ultrasound and AFP every 6 months |
| LAASL[@26243] |
2014 |
In cirrhotic patients ultrasound should be performed every 6 months
If quality ultrasound is not available, AFP level may be considered as a biomarker
|